Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy-Reference-Cited by-同舟云学术

Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy

Published:2022 Issue:6 Volume:36 Page:375
ISSN:1674-8301
Container-title:The Journal of Biomedical Research
language:
Short-container-title:J Biomed Res

Author:

Naryzhnaya Natalia V.,Maslov Leonid N.,Popov Sergey V.,Mukhomezyanov Alexandr V.,Ryabov Vyacheslav V.,Kurbatov Boris K.,Gombozhapova Alexandra E.,Singh Nirmal,Fu Feng,Pei Jian-Ming,Logvinov Sergey V.

Publisher

Journal of Biomedical Research

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.jbr-pub.org.cn/fileSWYXYJZZYWB/journal/article/swyxyjzzywb/2022/6/JBR-2022-0123.pdf

Reference112 articles.

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association[J]. Circulation, 2015, 131(4): e29–e322.

2. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association[J]. Circulation, 2018, 137(12): e67–e492.

3. De Geest B, Mishra M. Role of high-density lipoproteins in cardioprotection and in reverse remodeling: therapeutic implications[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2021, 1866(11): 159022.

4. D'Elia N, D'hooge J, Marwick TH. Association between myocardial mechanics and ischemic LV remodeling[J]. JACC Cardiovasc Imaging, 2015, 8(12): 1430–1443.

5. van der Bijl P, Abou R, Goedemans L, et al. Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern Era[J]. JACC Heart Fail, 2020, 8(2): 131–140.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches;Archives of Biochemistry and Biophysics;2024-09

2. Do platelets protect the heart against ischemia/reperfusion injury or exacerbate cardiac ischemia/reperfusion injury? The role of PDGF, VEGF, and PAF;Life Sciences;2024-06

3. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists;International Journal of Molecular Sciences;2024-04-30

4. Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism;Fundamental & Clinical Pharmacology;2024-02-04

5. Prognostic significance of IL‐18 in acute coronary syndrome patients;Clinical Cardiology;2024-01-29